Apeiron Investment Group Limited became the largest shareholder of Atai Life Sciences on July 3, 2025.
2 reports, 0 independent
Updated Jul 3
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Apeiron Investment Group Limited became the largest shareholder of Atai Life Sciences on July 3, 2025.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Apeiron Investment Group Limited is the largest shareholder of Atai Life Sciences.
- Atai's financing round involved Apeiron and placement agents TD Cowen/Leerink, while seeking FDA discussion.
Keep exploring
The entities involved
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet